Ani Pharmaceuticals (ANIP) Free Cash Flow (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Free Cash Flow of $52.3 million for Q1 2026, up 24.8% sequentially from $41.9 million in Q4 2025, and up 53.97% YoY from $34.0 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Free Cash Flow (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Free Cash Flow for 17 years, with the latest figure at $52.3 million in Q1 2026.
- Quarterly Free Cash Flow rose 53.97% year-over-year to $52.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $202.5 million (up 151.84% YoY) and the FY2025 annual result came in at $184.2 million, up 190.09% from the prior year.
- Free Cash Flow rose to $52.3 million in Q1 2026 per ANIP's latest filing, from $41.9 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $70.3 million in Q2 2025 and troughed at -$19.2 million in Q1 2022.
- A 5-year average of $22.8 million and a median of $19.1 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow sank 1638.06% in 2022, then soared 15080.8% in 2025.
- Over 5 years, Free Cash Flow stood at -$4.6 million in 2022, then surged by 1060.82% to $44.7 million in 2023, then tumbled by 34.68% to $29.2 million in 2024, then surged by 43.65% to $41.9 million in 2025, then climbed by 24.8% to $52.3 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $52.3 million, $41.9 million, and $38.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 53.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.62 Mn |
| Jun 30, 2026 | 53.62 Mn |
| Mar 31, 2026 | 52.30 Mn |
| Mar 31, 2026 | 52.30 Mn |
| Dec 31, 2025 | 41.91 Mn |
| Dec 31, 2025 | 41.91 Mn |
| Sep 30, 2025 | 37.95 Mn |
| Sep 30, 2025 | 37.95 Mn |
| Jun 30, 2025 | 70.35 Mn |
| Jun 30, 2025 | 70.35 Mn |
| Mar 31, 2025 | 33.97 Mn |
| Mar 31, 2025 | 33.97 Mn |
| Dec 31, 2024 | 29.17 Mn |
| Dec 31, 2024 | 29.17 Mn |
| Sep 30, 2024 | 250,000.00 |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 17.02 Mn |
| Jun 30, 2024 | 17.02 Mn |
| Mar 31, 2024 | 17.05 Mn |
| Mar 31, 2024 | 17.05 Mn |